Overall Earnings Trend and Market Cap Analysis

The latest quarter saw a marked increase in the proportion of companies reporting positive results, rising to 56.0% from 46.0% in December 2025, 44.0% in September 2025, and 41.0% in June 2025. This upward trajectory suggests improving business conditions and operational efficiencies across the board.

Breaking down the results by market capitalisation, mid-cap companies led the charge with 66.0% posting positive earnings, outperforming both small caps at 55.0% and large caps at 50.0%. This trend highlights the resilience and growth potential of mid-sized firms in the current economic environment, possibly benefiting from nimble business models and sectoral tailwinds.

Large caps, while showing a more modest 50.0% positive result rate, still contributed significant headline performances, with key players like Muthoot Finance in the Non-Banking Financial Company (NBFC) sector delivering strong earnings beats. Meanwhile, small caps demonstrated pockets of exceptional performance, particularly in sectors such as Realty and Specialty Chemicals.

Sectoral Highlights and Top Performers

Among large caps, Muthoot Finance stood out with robust earnings in the NBFC sector, reflecting sustained demand for credit and effective risk management. The company’s performance underscores the sector’s gradual recovery amid tightening regulatory scrutiny and competitive pressures.

Mid-cap companies also showcased strong results, with Multi Commodity Exchange (Multi Comm. Exc.) in the Capital Markets sector delivering impressive earnings growth. This performance is indicative of increased market activity and investor participation, which have buoyed trading volumes and revenue streams.

Small caps produced some of the most remarkable results, with Puravankara in Realty, Navin Fluorine International in Specialty Chemicals, and Thangamayil Jewellery in Gems, Jewellery and Watches emerging as top performers. These companies benefited from sector-specific tailwinds such as rising real estate demand, specialty chemical exports, and festive season jewellery sales respectively.

Exceptional Quarterly Performance: Viyash Scientific Ltd.

In the last 24 hours, Viyash Scientific Ltd., a Pharmaceuticals & Biotechnology firm with a market size of ₹9,906 crores, declared outstanding results for the March 2026 quarter. The company’s net sales surged by 129.02% to ₹919.96 crores, marking the highest quarterly sales in its history.

Operating profit to interest ratio reached an impressive 12.69 times, reflecting strong operational efficiency and prudent financial management. Profit before tax (excluding other income) soared by 629.29% to ₹109.32 crores, while net profit after tax grew by 446.4% to ₹52.11 crores. These figures represent record highs for the company, with PBDIT also peaking at ₹184.25 crores.

Despite a slight decline in its Mojo score from 35 to 33 over the past three months, Viyash Scientific’s financial performance remains robust, signalling strong fundamentals and growth prospects in the pharmaceutical sector.

Upcoming Earnings to Watch

Investors will be closely monitoring the results of several heavyweight companies scheduled to announce earnings on 21 May 2026. These include Max Healthcare Institute Ltd, GAIL (India) Ltd, and ITC Ltd. Their performance will provide further clarity on sectoral momentum and broader market trends heading into the second half of the fiscal year.

Implications for Investors and Market Outlook

The improving trend in positive quarterly results across market caps and sectors suggests a cautiously optimistic outlook for the Indian equity markets. Mid-cap companies, in particular, appear well-positioned to capitalise on growth opportunities, supported by favourable sector dynamics and operational agility.

Large caps continue to provide stability and steady earnings growth, while small caps offer selective opportunities with high growth potential, albeit with greater volatility. Investors should consider a balanced approach, focusing on quality companies with strong fundamentals and sustainable earnings momentum.

Overall, the March 2026 earnings season reinforces the narrative of gradual economic recovery and corporate resilience, with many companies demonstrating improved profitability and operational leverage despite ongoing macroeconomic challenges.

Conclusion

The March quarter results have delivered encouraging signs of earnings recovery, with a majority of companies reporting positive outcomes and several posting record financial metrics. The strong showing by mid and small caps, alongside steady large-cap performances, provides a diversified landscape for investors seeking growth and stability.

As the market awaits the upcoming results of key players next week, the current earnings season sets a constructive tone for the months ahead, underscoring the importance of selective stock picking and sectoral analysis in navigating the evolving market environment.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →